Cargando…

Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources

Hospitalized patients require the use of a variety of drugs, many of which individually or in combination have the potential to cause kidney damage. The use of potentially nephrotoxic drugs is often unavoidable, and the need for dose adjustment should be evaluated. This study is aimed at assessing c...

Descripción completa

Detalles Bibliográficos
Autores principales: Bicalho, Millena Drumond, Soares, Danielly Botelho, Botoni, Fernando Antonio, Reis, Adriano Max Moreira, Martins, Maria Auxiliadora Parreiras
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586671/
https://www.ncbi.nlm.nih.gov/pubmed/26371029
http://dx.doi.org/10.3390/ijerph120911227
_version_ 1782392409535021056
author Bicalho, Millena Drumond
Soares, Danielly Botelho
Botoni, Fernando Antonio
Reis, Adriano Max Moreira
Martins, Maria Auxiliadora Parreiras
author_facet Bicalho, Millena Drumond
Soares, Danielly Botelho
Botoni, Fernando Antonio
Reis, Adriano Max Moreira
Martins, Maria Auxiliadora Parreiras
author_sort Bicalho, Millena Drumond
collection PubMed
description Hospitalized patients require the use of a variety of drugs, many of which individually or in combination have the potential to cause kidney damage. The use of potentially nephrotoxic drugs is often unavoidable, and the need for dose adjustment should be evaluated. This study is aimed at assessing concordance in information on drug-induced nephrotoxicity and dose adjustment recommendations by comparing four drug information sources (DRUGDEX(®), UpToDate(®), Medscape(®) and the Brazilian Therapeutic Formulary) using the formulary of a Brazilian public hospital. A total of 218 drugs were investigated. The global Fleiss’ kappa coefficient was 0.265 for nephrotoxicity (p < 0.001; CI 95%, 0.211–0.319) and 0.346 for recommendations (p < 0.001; CI 95%, 0.292–0.401), indicating fair concordance among the sources. Anti-infectives and anti-hypertensives were the main drugs cited as nephrotoxic by the different sources. There were no clear definitions for qualitative data or quantitative values for dose adjustments among the four information sources. There was no advice for dosing for a large number of the drugs in the international databases. The National Therapeutic Formulary offered imprecise dose adjustment recommendations for many nephrotoxic drugs. Discrepancies among information sources may have a clinical impact on patient care and contribute to drug-related morbidity and mortality.
format Online
Article
Text
id pubmed-4586671
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-45866712015-10-06 Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources Bicalho, Millena Drumond Soares, Danielly Botelho Botoni, Fernando Antonio Reis, Adriano Max Moreira Martins, Maria Auxiliadora Parreiras Int J Environ Res Public Health Article Hospitalized patients require the use of a variety of drugs, many of which individually or in combination have the potential to cause kidney damage. The use of potentially nephrotoxic drugs is often unavoidable, and the need for dose adjustment should be evaluated. This study is aimed at assessing concordance in information on drug-induced nephrotoxicity and dose adjustment recommendations by comparing four drug information sources (DRUGDEX(®), UpToDate(®), Medscape(®) and the Brazilian Therapeutic Formulary) using the formulary of a Brazilian public hospital. A total of 218 drugs were investigated. The global Fleiss’ kappa coefficient was 0.265 for nephrotoxicity (p < 0.001; CI 95%, 0.211–0.319) and 0.346 for recommendations (p < 0.001; CI 95%, 0.292–0.401), indicating fair concordance among the sources. Anti-infectives and anti-hypertensives were the main drugs cited as nephrotoxic by the different sources. There were no clear definitions for qualitative data or quantitative values for dose adjustments among the four information sources. There was no advice for dosing for a large number of the drugs in the international databases. The National Therapeutic Formulary offered imprecise dose adjustment recommendations for many nephrotoxic drugs. Discrepancies among information sources may have a clinical impact on patient care and contribute to drug-related morbidity and mortality. MDPI 2015-09-09 2015-09 /pmc/articles/PMC4586671/ /pubmed/26371029 http://dx.doi.org/10.3390/ijerph120911227 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Bicalho, Millena Drumond
Soares, Danielly Botelho
Botoni, Fernando Antonio
Reis, Adriano Max Moreira
Martins, Maria Auxiliadora Parreiras
Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title_full Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title_fullStr Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title_full_unstemmed Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title_short Drug-Induced Nephrotoxicity and Dose Adjustment Recommendations: Agreement Among Four Drug Information Sources
title_sort drug-induced nephrotoxicity and dose adjustment recommendations: agreement among four drug information sources
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4586671/
https://www.ncbi.nlm.nih.gov/pubmed/26371029
http://dx.doi.org/10.3390/ijerph120911227
work_keys_str_mv AT bicalhomillenadrumond druginducednephrotoxicityanddoseadjustmentrecommendationsagreementamongfourdruginformationsources
AT soaresdaniellybotelho druginducednephrotoxicityanddoseadjustmentrecommendationsagreementamongfourdruginformationsources
AT botonifernandoantonio druginducednephrotoxicityanddoseadjustmentrecommendationsagreementamongfourdruginformationsources
AT reisadrianomaxmoreira druginducednephrotoxicityanddoseadjustmentrecommendationsagreementamongfourdruginformationsources
AT martinsmariaauxiliadoraparreiras druginducednephrotoxicityanddoseadjustmentrecommendationsagreementamongfourdruginformationsources